Aldeyra Therapeutics Inc.
(ALDX)
undefined
undefined%
At close: undefined
4.90
-0.81%
After-hours Dec 13, 2024, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Net Income | -37.54M | -62.02M | -57.78M | -37.55M | -60.83M | -38.89M | -22.34M | -18.70M | -12.09M | -5.19M | 13.06M | -23.07M | -2.38M |
| Depreciation & Amortization | 262.78K | 258.71K | 264.18K | 56.22K | 96.31K | 71.00K | 37.85K | 35.79K | 18.78K | 1.07K | - | 3.74K | 1.59K |
| Stock-Based Compensation | 5.75M | 8.29M | 7.11M | 7.08M | 8.08M | 4.14M | 2.71M | 2.76M | 2.19M | 2.04M | 1.70M | 84.40K | 49.59K |
| Other Working Capital | -343.25K | -2.56M | 6.80M | -8.40M | 5.59M | 2.95M | -510.07K | 1.04M | 26.96K | 550.33K | -9.69K | 44.50K | 99.65K |
| Other Non-Cash Items | 339.65K | 283.90K | 409.47K | 2.23M | 6.23M | 59.32K | 20.34K | 27.31K | 35.83K | 150.85K | -16.73M | 21.98M | - |
| Deferred Income Tax | - | - | - | -479.26K | -1.31M | -237.54K | 129.25K | 266.11K | - | -2.33M | - | 134.50K | - |
| Change in Working Capital | 861.18K | -3.44M | 7.44M | -8.83M | 2.74M | 5.00M | 215.45K | 462.97K | 536.83K | 549.77K | 259.62K | 91.74K | -65.88K |
| Operating Cash Flow | -30.33M | -56.64M | -42.56M | -37.49M | -44.98M | -29.86M | -19.22M | -15.15M | -9.31M | -4.78M | -1.71M | -778.05K | -2.39M |
| Capital Expenditures | - | -16.32K | -7.81K | - | -9.53K | -262.97K | -24.76K | -11.81K | -86.12K | -14.06K | - | - | - |
| Acquisitions | - | 16.32K | - | - | 609.46K | 262.97B | 24.76B | 11.81K | - | - | - | - | - |
| Purchase of Investments | - | -92.94M | - | -5.78M | -57.77M | -59.73M | -35.10M | -16.05M | -12.95M | - | - | - | - |
| Sales Maturities Of Investments | 30.00M | 63.00M | - | 34.80M | 75.64M | 36.66M | 24.92M | 15.84M | - | - | - | - | - |
| Other Investing Acitivies | - | -16.32K | -7.81B | 29.02K | 18.49K | -262.97B | -24.76B | -11.81K | -12.95M | -14.06K | - | - | - |
| Investing Cash Flow | 30.00M | -29.95M | -7.81K | 29.02M | 18.48M | -23.34M | -10.20M | -225.23K | -13.04M | -14.06K | - | - | - |
| Debt Repayment | -1.04M | - | - | - | 14.45M | - | - | - | - | - | 1.07M | 500.00K | - |
| Common Stock Repurchased | -532.95K | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Financial Acitivies | -227.72K | 1.22M | 4.68M | 1.19M | 1.23M | -1.31M | -165.93K | - | -36.24K | - | 2.67M | 1.25M | - |
| Financial Cash Flow | -1.27M | 1.22M | 194.50M | 41.90M | 23.58M | 80.53M | 37.43M | 12.74M | 28.47M | 10.06M | 3.75M | 1.75M | - |
| Net Cash Flow | -1.60M | -85.37M | 151.93M | 33.43M | -2.93M | 27.33M | 8.01M | -2.63M | 6.12M | 5.26M | 2.04M | 972.68K | -2.39M |
| Free Cash Flow | -30.33M | -56.65M | -42.56M | -37.49M | -44.99M | -30.12M | -19.25M | -15.16M | -9.40M | -4.79M | -1.71M | -778.05K | -2.39M |